Stroke Ischemic clinical trials

Explore recruiting stroke ischemic clinical trials.

Recruiting stroke ischemic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stroke Ischemic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation

Spain, Austria, Czechia, Greece, Belgium, Italy +4 more

Therapeutic use (Phase IV) EU CTIS Study details

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)

Finland, France, Spain

Therapeutic use (Phase IV) EU CTIS Study details

RIISC Evaluation of low dose colchicine in prevention of ischemic stroke in patients with stroke due to atherosclerosis. Reducing inflammation in ischemic stroke with colchicine (riisc),

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Adjunctive DobutAmine in sePtic cardiomyopathy with Tissue hypoperfusion: a randomized controlled multi-center trial

France

Phase III and phase IV (Integrated) EU CTIS Study details

Effect of vasopressin versus norepinephrine on post-operative mean pulmonary arterial pressure following pulmonary endarterectomy surgery, a randomized open label trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

EUROpean pragmatic multicenter randomized trial on platelet inhibition and/or lipid lowering treatment in Covert Brain Infarction (CBI)

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stroke Ischemic trials by city

Stroke Ischemic in Toronto Stroke Ischemic in Vancouver Stroke Ischemic in Montreal Stroke Ischemic in Calgary Stroke Ischemic in Edmonton Stroke Ischemic in Ottawa Stroke Ischemic in Winnipeg Stroke Ischemic in Quebec City Stroke Ischemic in Hamilton Stroke Ischemic in Kitchener Stroke Ischemic in London Stroke Ischemic in Halifax Stroke Ischemic in New York Stroke Ischemic in Los Angeles Stroke Ischemic in Chicago Stroke Ischemic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease